Telix Pharmaceuticals (Australia) Today
| TLX Stock | 27.98 0.18 0.65% |
PerformanceOK
| Odds Of DistressVery Small
|
Telix Pharmaceuticals is selling for under 27.98 as of the 22nd of March 2025; that is 0.65 percent increase since the beginning of the trading day. The stock's last reported lowest price was 27.81. Telix Pharmaceuticals has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Moving together with Telix Stock
Moving against Telix Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Telix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Telix Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Telix Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Japan | Shintaro BSc |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Telix Pharmaceuticals (TLX) is traded on Australian Securities Exchange in Australia and employs 27 people. Telix Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telix Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Telix Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Telix Pharmaceuticals operates under Biotechnology sector and is part of Health Care industry. The entity has 334.72 M outstanding shares.
Telix Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check Telix Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationTelix Pharmaceuticals shows a total of 334.72 Million outstanding shares. Telix Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Telix Ownership Details
Telix Pharmaceuticals Risk Profiles
Although Telix Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Telix Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.72 | |||
| Semi Deviation | 1.87 | |||
| Standard Deviation | 2.64 | |||
| Variance | 6.96 |
Telix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Telix Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Telix Pharmaceuticals Corporate Management
Elected by the shareholders, the Telix Pharmaceuticals' board of directors comprises two types of representatives: Telix Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telix. The board's role is to monitor Telix Pharmaceuticals' management team and ensure that shareholders' interests are well served. Telix Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telix Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin MBA | Chief Medicine | Profile | |
| Meredith Crowe | Interim Culture | Profile | |
| BSc BSc | Chief Scientist | Profile | |
| Christian Davis | EMEA Marketing | Profile | |
| Darren PharmD | Group Officer | Profile | |
| Kyahn Williamson | Sr Relations | Profile | |
| MBA MD | Group Officer | Profile |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.